321699007: Product containing haloperidol decanoate (medicinal product)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3653503015 Product containing haloperidol decanoate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3653504014 Product containing haloperidol decanoate (medicinal product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3666193014 Haloperidol decanoate product en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

233951000077111 décanoate d'halopéridol fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

756841000172112 produit contenant du décanoate d'halopéridol fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
décanoate d'halopéridol	Is a	Product containing haloperidol (medicinal product)	false	Inferred relationship	Some
décanoate d'halopéridol	Is a	Haloperidol-containing product in parenteral dose form	false	Inferred relationship	Some
décanoate d'halopéridol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Phenylbutylpiperadine derivative antipsychotic agent	false	Inferred relationship	Some
décanoate d'halopéridol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Haloperidol (substance)	false	Inferred relationship	Some
décanoate d'halopéridol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Haloperidol decanoate (substance)	false	Inferred relationship	Some
décanoate d'halopéridol	Has manufactured dose form	injection	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
halopéridol 50 mg/1 mL, injection huileuse	Is a	False	décanoate d'halopéridol	Inferred relationship	Some
halopéridol 100 mg/1 mL, injection huileuse	Is a	False	décanoate d'halopéridol	Inferred relationship	Some
Haloperidol decanoate adverse reaction	Causative agent (attribute)	False	décanoate d'halopéridol	Inferred relationship	Some
allergie au décanoate d'halopéridol	Causative agent (attribute)	False	décanoate d'halopéridol	Inferred relationship	Some
Haloperidol decanoate 50mg/mL injection solution ampule	Is a	False	décanoate d'halopéridol	Inferred relationship	Some
Haloperidol decanoate 50mg/mL solution	Is a	False	décanoate d'halopéridol	Inferred relationship	Some
Haloperidol 100mg injection solution ampule	Is a	False	décanoate d'halopéridol	Inferred relationship	Some
Product containing precisely haloperidol (as haloperidol decanoate) 100 milligram/1 milliliter prolonged-release oil for injection ampule	Is a	False	décanoate d'halopéridol	Inferred relationship	Some
Product containing precisely haloperidol (as haloperidol decanoate) 50 milligram/1 milliliter prolonged-release oil for injection ampule	Is a	False	décanoate d'halopéridol	Inferred relationship	Some

Reference Sets

Concept inactivation indicator reference set